Eli Lilly Total Assets 2006-2019 | LLY

Eli Lilly total assets from 2006 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Eli Lilly total assets for the quarter ending June 30, 2019 were $38.666B, a 8.72% decline year-over-year.
  • Eli Lilly total assets for 2018 were $43.908B, a 2.38% decline from 2017.
  • Eli Lilly total assets for 2017 were $44.981B, a 15.91% increase from 2016.
  • Eli Lilly total assets for 2016 were $38.806B, a 9.1% increase from 2015.
Eli Lilly Annual Total Assets
(Millions of US $)
2018 $43,908
2017 $44,981
2016 $38,806
2015 $35,569
2014 $36,308
2013 $35,249
2012 $34,399
2011 $33,660
2010 $31,001
2009 $27,461
2008 $29,213
2007 $26,875
2006 $21,955
2005 $24,581
Eli Lilly Quarterly Total Assets
(Millions of US $)
Q2 2019 $38,666
Q1 2019 $38,007
Q4 2018 $43,908
Q3 2018 $44,625
Q2 2018 $42,359
Q1 2018 $44,356
Q4 2017 $44,981
Q3 2017 $43,010
Q2 2017 $40,947
Q1 2017 $37,624
Q4 2016 $38,806
Q3 2016 $37,590
Q2 2016 $36,475
Q1 2016 $34,692
Q4 2015 $35,569
Q3 2015 $36,305
Q2 2015 $36,037
Q1 2015 $35,654
Q4 2014 $36,308
Q3 2014 $34,649
Q2 2014 $35,018
Q1 2014 $34,757
Q4 2013 $35,249
Q3 2013 $33,966
Q2 2013 $33,226
Q1 2013 $32,300
Q4 2012 $34,399
Q3 2012 $34,321
Q2 2012 $31,813
Q1 2012 $32,238
Q4 2011 $33,660
Q3 2011 $33,042
Q2 2011 $32,779
Q1 2011 $31,695
Q4 2010 $31,001
Q3 2010 $29,904
Q2 2010 $27,723
Q1 2010 $27,198
Q4 2009 $27,461
Q3 2009 $27,128
Q2 2009 $26,932
Q1 2009 $26,597
Q4 2008 $29,213
Q3 2008 $27,707
Q2 2008 $27,752
Q1 2008 $27,220
Q4 2007 $26,875
Q3 2007 $24,974
Q2 2007 $24,056
Q1 2007 $23,733
Q4 2006 $21,955
Q3 2006 $23,913
Q2 2006 $24,436
Q1 2006 $24,147
Q4 2005 $24,581
Q3 2005 $24,803
Q2 2005 $23,420
Q1 2005 $23,240
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $106.420B $24.556B
Eli Lilly and Company is a global healthcare leader that unites caring with discovery to make life better for people around the world. They were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and they remain true to that mission in all their work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $344.517B 15.01
Roche Holding AG (RHHBY) Switzerland $236.162B 0.00
Merck (MRK) United States $213.689B 17.57
Novartis AG (NVS) Switzerland $203.229B 17.47
Pfizer (PFE) United States $190.711B 11.23
Novo Nordisk (NVO) Denmark $124.306B 20.63
AstraZeneca (AZN) United Kingdom $111.903B 22.43
Sanofi (SNY) France $103.972B 12.81
GlaxoSmithKline (GSK) United Kingdom $99.125B 12.53
AbbVie (ABBV) United States $93.115B 7.46
Bristol-Myers Squibb (BMY) United States $74.836B 10.61
Bayer (BAYRY) Germany $65.462B 9.54
H Lundbeck (HLUYY) Denmark $7.938B 11.45